NCT07115810Completed
No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort
Source: ClinicalTrials.gov · Last updated 11 Aug 2025
Brief summary (registry, in English)
The goal of this observational study is to compare the clinical outcomes, molecular features, and immune profiles of patients with synchronous and metachronous distant metastases in Saudi cohort with well characterized differentiated thyroid cancer. The main question it aims to answer is whether timing of metastasis is associated with distinct prognostic or biological behavior in differentiated thyroid cancer from a large Middle Eastern cohort
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 178 (actual)
- First submitted
- 4 Aug 2025
- Start date
- 1 Jan 1988
- Primary completion date
- 31 Dec 2018
- Lead sponsor
- King Faisal Specialist Hospital & Research Center
- Diseases
- Thyroid cancer, Childhood cancers
- NCT number
- NCT07115810
What you commit to
- Study type: Observational
- Participants enrolled: 178
- From 1 Jan 1988 to the primary completion date, 31 Dec 2018
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not DTC
- No distant metastases
Who the study is looking for
- Synchronous or metachronous distant metastases
Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.